- Home
- RVPH vs VIVK Comparison
RVPH vs VIVK Comparison
Compare RVPH & VIVK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- VIVK
- Stock Information
- Founded
- RVPH 2006
- VIVK 2006
- Country
- RVPH United States
- VIVK United States
- Employees
- RVPH N/A
- VIVK N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- VIVK Oilfield Services/Equipment
- Sector
- RVPH Health Care
- VIVK Energy
- Exchange
- RVPH Nasdaq
- VIVK Nasdaq
- Market Cap
- RVPH 32.8M
- VIVK 38.4M
- IPO Year
- RVPH N/A
- VIVK N/A
- Fundamental
- Price
- RVPH $0.37
- VIVK $0.77
- Analyst Decision
- RVPH Strong Buy
- VIVK
- Analyst Count
- RVPH 5
- VIVK 0
- Target Price
- RVPH $9.00
- VIVK N/A
- AVG Volume (30 Days)
- RVPH 2.6M
- VIVK 264.5K
- Earning Date
- RVPH 08-13-2025
- VIVK 08-15-2025
- Dividend Yield
- RVPH N/A
- VIVK N/A
- EPS Growth
- RVPH N/A
- VIVK N/A
- EPS
- RVPH N/A
- VIVK N/A
- Revenue
- RVPH N/A
- VIVK $111,130,140.00
- Revenue This Year
- RVPH N/A
- VIVK N/A
- Revenue Next Year
- RVPH N/A
- VIVK N/A
- P/E Ratio
- RVPH N/A
- VIVK N/A
- Revenue Growth
- RVPH N/A
- VIVK 85.84
- 52 Week Low
- RVPH $0.30
- VIVK $0.55
- 52 Week High
- RVPH $4.28
- VIVK $3.42
- Technical
- Relative Strength Index (RSI)
- RVPH 30.28
- VIVK 45.56
- Support Level
- RVPH $0.35
- VIVK $0.76
- Resistance Level
- RVPH $0.83
- VIVK $1.01
- Average True Range (ATR)
- RVPH 0.07
- VIVK 0.11
- MACD
- RVPH -0.04
- VIVK -0.01
- Stochastic Oscillator
- RVPH 11.32
- VIVK 30.99
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About VIVK Vivakor Inc.
Vivakor Inc is a socially responsible operator, acquirer and developer of technologies and assets in the oil and gas industry, as well as related environmental solutions. It is focused on operating crude oil gathering, storage and transportation facilities, as well as contaminated soil remediation services. Company have two operating business segments: Transportation logistics services; Terminaling and storage facility product and services related to oil and gas production. Majority of revenue is from Terminaling and storage segment.